Human Experience Dynamics

Name

Human Experience Dynamics

Legal name

Human Experience Dynamics Ltd

Website

https://hed.healthcare

Company type

Private

Founded year

2018

Operating status

Operating

Headcount range

1–10 employees

Ownership category

akta.pro rank

Product category

Clinical Trial Endpoints

NAICS

Scientific Research and Development Services (5417)

SIC

Services-Computer Programming Services (7371), Services-Computer Programming, Data Processing, Etc. (7370)

akta.pro industry

PRIMARYHLACANAM

DTx/SaMD Evidence, Outcomes & Real-World Data (RWE) Platforms

Healthcare & Life Sciences/Digital Health & Health IT/Digital Therapeutics (DTx) & Software as a Medical Device (SaMD)

SECONDARYHLACANAG

SaMD – Imaging & Signal Analysis (AI/ML)

Healthcare & Life Sciences/Digital Health & Health IT/Digital Therapeutics (DTx) & Software as a Medical Device (SaMD)

SECONDARYHLAHACAE

Neurological Monitoring (EEG, Seizure/Sleep/Neuro Wearables)

Healthcare & Life Sciences/Medical Devices & Diagnostics/Patient Monitoring, Wearables & Remote Diagnostics

Keywords

• Clinical trial endpoints
• CNS clinical research
• Patient experience data
• Psychiatric trial design
• Digital biomarkers

Headquarters

HQ city

Cambridge

HQ country

United Kingdom

HQ region

Europe

Offices1 record

Markets served

GTM type

B2B

Offering type

Software

Cost components

Personnel, Technology or R&D, Operations, Marketing or Sales, Infrastructure

Revenue model

1. Clinical Trial Endpoint Services: HED provides endpoint intelligence services for psychiatric and CNS clinical trials, integrating Traces™ data collection into existing trial protocols. Revenue is generated through service contracts with pharma sponsors, CROs, and wearables companies conducting clinical trials.

Go-to-market motion2 records

Distribution channels3 records

Marketing channels3 records

Core offering

HED provides endpoint intelligence services for psychiatric and CNS clinical trials through Traces (Temporal Experience Tracing™), a validated data collection methodology that captures continuous daily symptom experience as patient-drawn curves on a mobile device. The platform integrates experience data with EEG, wearable, sleep, and activity signals, then delivers a real-time monitoring dashboard and a regulatory-grade clinical report ready for FDA and EMA submission at trial end.

Product overview

Human Experience Dynamics offers a single unified product called Traces (Temporal Experience Tracing™), which serves as the company's endpoint intelligence platform for psychiatric and CNS clinical trials. The product enables continuous daily symptom tracking through patient-drawn experience curves, integrating with physiological data sources and delivering regulatory-grade clinical reports for trial submission.

Differentiator

Problem solved

Functional benefit

Brands

• Traces™: Temporal Experience Tracing™ (TET) is a validated data collection method that captures how patients experience their symptoms continuously throughout each day. Patients draw a continuous curve on their phone or tablet showing symptom fluctuations across the day. Each evening trace captures 100× more data per participant than standard questionnaires.

Products and services

• Traces (Temporal Experience Tracing™) A validated data collection methodology and endpoint intelligence platform for psychiatric and CNS clinical trials. Patients draw a continuous curve on a mobile device each evening showing how their symptoms fluctuated throughout the day, generating a rich time-series dataset with 100× more data per participant than standard biweekly questionnaires. Traces integrates with EEG, wearable signals, sleep tracking, and activity monitoring, and includes a real-time monitoring dashboard and regulatory-grade clinical report for FDA and EMA submission. The product is designed for pharma sponsors, CROs, and wearables companies running clinical trials in psychiatric, CNS, and digital therapeutic indications.

Quantifiable outcome

• 3.5× greater statistical power by capturing patient-specific daily variance of symptoms
• +3 more outcomes

Segments3 records

Ideal customer profiles3 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature4 records

Partnerships

Five partnerships are on record, tiered core and minor.

• Cambridge EnterprisecoreOthersCambridge Enterprise is the technology transfer office of the University of Cambridge. HED is a University of Cambridge spinout, indicating Cambridge Enterprise involvement in the commercialization and licensing of the foundational research.
• BitbraincoreTechnology or IntegrationBitbrain collaboration on auditory closed-loop deep sleep stimulation for Mild Cognitive Impairment patients. Currently in progress. Bitbrain provides wearable/neurotechnology hardware that integrates with HED's experience data layer.
• Royal Papworth Hospital NHS Foundation TrustcoreStrategic or Co-development PartnerNHS foundation trust hospital collaborating with HED on clinical research, providing clinical trial infrastructure and patient access for validation studies.
• Cambridgeshire and Peterborough NHS Foundation TrustcoreStrategic or Co-development PartnerNHS foundation trust providing clinical research collaboration and access to patient populations for HED's clinical validation studies in psychiatric conditions.
• Universidad de GranadaminorStrategic or Co-development PartnerAcademic collaboration with the University of Granada in Spain, supporting research publications and academic validation of the TET methodology.

Scale indicators8 records

Recent moves7 records

Expansion highlights5 records

Broad incumbents

• Medidata (Dassault Systèmes): Dominant eClinical/eCOA platform serving the majority of large pharma trials. Comparable as the incumbent endpoint technology stack HED integrates with or competes against for endpoint intelligence in CNS and psychiatric protocols.
• Signant Health: Leading eCOA and digital endpoint provider with deep CNS/psychiatry trial experience (formerly Bracket). Comparable as an incumbent specializing in subjective endpoint capture for psychiatric trials that HED's continuous tracing methodology targets.
• Evidera (PPD / Thermo Fisher Scientific): Major HEOR and real-world evidence services provider for pharma. Comparable as a broad incumbent in the regulatory-grade clinical evidence space that HED's endpoint intelligence and regulatory reporting competes with or complements in CNS trials.
• Clario: Major clinical trial endpoint technology provider (eCOA, imaging, cardiac safety). Comparable as a broad incumbent delivering endpoint solutions that HED's TET method could either complement or compete with in CNS trials.

Direct peers

• IXICO: UK-based neuroimaging biomarker company serving CNS clinical trials. Comparable as a peer providing validated digital endpoints for psychiatric/neurological drug development, sharing HED's CNS focus and regulatory positioning.
• Cambridge Cognition: UK-based provider of cognitive assessments and digital endpoints for CNS clinical trials. Highly comparable as a Cambridge-affiliated company offering validated digital measures for psychiatric and neurodegenerative trials, overlapping directly with HED's CNS endpoint intelligence offering.
• Koneksa: Digital biomarker company developing validated sensor-based endpoints for clinical trials across CNS and other indications. Comparable as a direct peer building regulatory-grade digital evidence from continuous patient data.
• VivoSense: Digital biomarker and wearable endpoint company for clinical trials. Comparable as a focused peer combining physiological sensor data with clinical endpoint generation, mirroring HED's experience-physiology integration thesis.

Emerging players

• Castor: eClinical platform offering eCRF, ePRO, and decentralized trial capabilities. Comparable as an emerging platform expanding into endpoint data capture for clinical trials, with partial overlap to HED's patient-reported experience layer.
• ActiGraph: Wearable activity and sleep monitoring hardware/analytics used in clinical trials. Comparable as a partner-adjacent peer providing the physiological data stream that HED integrates with for combined experience-physiology analysis.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks5 records

Key highlights6 records

Customer concentration

• LinkedInlinkedin.com/company/human-experience-dynamics

Revenue estimate

Valuation estimate

Number of profiles

Profiles2 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Human Experience Dynamics